| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 09/17/2003 | CN1443187A Fused cyclic compounds as modulators of nuclear hormone receptor function |
| 09/17/2003 | CN1443184A 嘧啶衍生物 Pyrimidine derivatives |
| 09/17/2003 | CN1443178A (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphtyl] -4-morpholibenzamide |
| 09/17/2003 | CN1443173A Substituted imidazoles as TAFI a inhibitors |
| 09/17/2003 | CN1443168A 5-chloro-3-(4-methane sulfonylphenyl)-6-methyl-[2,3'] bipyridine and process for synthesis |
| 09/17/2003 | CN1443164A Pyrrolidine derivatives as metalloprotease inhibitors |
| 09/17/2003 | CN1443163A Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors |
| 09/17/2003 | CN1443078A Testosterone ester formulation for human use |
| 09/17/2003 | CN1442196A Postpartum recovery pill and its preparation method |
| 09/17/2003 | CN1442189A Compound Chinese medicine for treating leukoplakia vulvae and its preparation method |
| 09/17/2003 | CN1442185A Medicine for treating uterus myoma disease and its preparation method |
| 09/17/2003 | CN1442182A Chinese medicine for treating impotence and its preparation method |
| 09/17/2003 | CN1442177A Health care wine for women |
| 09/17/2003 | CN1442176A External use medicine for treating vaginitis |
| 09/17/2003 | CN1442175A Chinese medicine for treating mammary gland foliole proliferation |
| 09/17/2003 | CN1442171A Medicinal powder for treating infertility of female animal |
| 09/16/2003 | USRE38253 Composition for contraception |
| 09/16/2003 | US6620842 Chalcones |
| 09/16/2003 | US6620820 Inhibitors of bone reabsorption and antagonists of vitronectin receptors |
| 09/16/2003 | US6620806 Estrogen agonist/antagonist to prevente myocardial infarction or stroke, maintaining or improving vascular reactivity, treat renal failure, peripheral arterial occlusive disease, coronary artery disease, or raynaud's phenomenon |
| 09/16/2003 | US6620801 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 09/16/2003 | US6620783 Human SMN-like protein (HSLP) and polynucleotides which identify and encode HSLP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating |
| 09/16/2003 | US6620782 compounds having Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or |
| 09/16/2003 | CA2249009C Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors |
| 09/16/2003 | CA2182183C Treatment of ovarian estrogen dependent conditions |
| 09/16/2003 | CA2019404C 11 beta-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents |
| 09/12/2003 | WO2003074483A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| 09/12/2003 | WO2003074469A1 Novel cinnamate salts, method for production and use thereof as medicaments |
| 09/12/2003 | WO2003074073A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 09/12/2003 | WO2003074037A1 Treatment of female sexual dysfunction |
| 09/12/2003 | WO2003051333B1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents |
| 09/12/2003 | WO2003039559B1 Pharmaceutical combinatons comprising a fungicide, a bacteriostatic sulphonamide and an antibacterial compound for topical application |
| 09/12/2003 | WO2003037268A3 Hepta-, octa- and nonapeptides having antiangiogenic activity |
| 09/12/2003 | WO2003034987A3 Androgen receptor modulators and methods of use thereof |
| 09/12/2003 | WO2002088314A3 Ovary-specific genes and proteins |
| 09/12/2003 | WO2002080966A3 Method for producing a vaccine containing autologous antibodies |
| 09/12/2003 | WO2002072830A3 Proteins associated with cell growth, differentiation, and death |
| 09/12/2003 | WO2002032961A8 Novel polypeptides and nucleic acids encoding same |
| 09/12/2003 | WO2001095785A3 Modulation of immune response and methods based thereon |
| 09/12/2003 | CA2477715A1 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient |
| 09/12/2003 | CA2477662A1 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 09/12/2003 | CA2477387A1 Treatment of female sexual dysfunction |
| 09/11/2003 | WO2003074449A2 Multi-substitued selective androgen receptor modulators and methods of use thereof |
| 09/11/2003 | US20030171556 Diagnosis and therapeutic treatment of Alzheimer's Disease; drug screening |
| 09/11/2003 | US20030171541 Selective binding agents, vectors, host cells, and methods for producing GPCR polypeptides; diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with GPCR polypeptides |
| 09/11/2003 | US20030171393 Drugs for sex dysfunctions |
| 09/11/2003 | US20030171384 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors |
| 09/11/2003 | US20030171380 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 09/11/2003 | US20030171361 Treatment of impotence, sexual dysfunction in female, stable, unstable and variant angina, hypertension, pulmonary hypertension, congestive heart failure, atherosclerosis |
| 09/11/2003 | US20030171352 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators |
| 09/11/2003 | US20030171323 Specifically for granuloma occurring after ligation of a deferent duct, comprising an antagonist against the scavenger receptor of macrophage, such as antibody, as an active ingredient. |
| 09/11/2003 | US20030171309 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 09/11/2003 | US20030171296 Pharmaceutical formulations for sustained drug delivery |
| 09/11/2003 | US20030171267 Albumin fusion proteins |
| 09/11/2003 | US20030171255 Modulating the phosphorylation of DARPP-32 in a serotonergic receptor intracellular signaling pathway. The invention provides methods and compositions for modulating the activities of DARPP-32, casein kinase 1 (CK1), |
| 09/11/2003 | US20030170292 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof |
| 09/11/2003 | US20030170286 Codrug with at least two constituent moieties cleavably linked covalently to one another; dimensioned to position two radiation seeds a predetermined distance apart. |
| 09/11/2003 | US20030170231 Remedies and preventives for antiphospholipid antibody syndrome |
| 09/10/2003 | EP1342721A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 09/10/2003 | EP1342410A2 Transgenic animals lacking a functional galanin gene |
| 09/10/2003 | EP1341920A2 Human elongase genes and uses thereof |
| 09/10/2003 | EP1341810A2 Secreted chlamydia polypeptides and method for identifying such polypeptides by their secretion by a type iii secretion pathway of a gram-negative bacteria. |
| 09/10/2003 | EP1341792A2 Amido ether substituted imidazoquinolines |
| 09/10/2003 | EP1341791A2 Thioether substituted imidazoquinolines |
| 09/10/2003 | EP1341790A2 Sulfonamido ether substituted imidazoquinolines |
| 09/10/2003 | EP1341789A2 Aryl ether substituted imidazoquinolines |
| 09/10/2003 | EP1341753A1 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 09/10/2003 | EP1341540A2 Tyrosine kinase inhibitors |
| 09/10/2003 | EP1341536A2 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine |
| 09/10/2003 | EP0921804B1 Biphasic oral contraceptive method and kit comprising a combination of a progestin and estrogen |
| 09/10/2003 | EP0912518B1 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 09/10/2003 | EP0851862B1 1(hetero)aryl-4-(condensed thiazol-2-ylalkyl)-piperazine derivatives, their preparation and their use in the treatment of 5-ht1a-receptor mediated disorders |
| 09/10/2003 | EP0737067B1 Treatment of hormone-unresponsive metastatic prostate cancer |
| 09/10/2003 | CN1441804A Tetrahydro-heterocyclozaepinyl pyrimidine derivatives |
| 09/10/2003 | CN1441801A Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors |
| 09/10/2003 | CN1441770A Modified forms of pharmacologically active agents and uses therefor |
| 09/10/2003 | CN1441666A Macromolecular drug complexes and compositions containing same |
| 09/10/2003 | CN1440811A Contraception vaccine cross-linked with molecular adjuvant |
| 09/10/2003 | CN1440807A Application of cyclosporin A in preparing anti-abortion medicine |
| 09/10/2003 | CN1440799A Women's medicine and its prepn |
| 09/10/2003 | CN1440776A Chinese medicine for regulating menstruation and nourishing blood |
| 09/10/2003 | CN1120713C Application of Chinese medicinal composition in preparing medicines |
| 09/09/2003 | US6617359 4-fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical |
| 09/09/2003 | US6617327 For therapy of depression and other diseases such as obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders |
| 09/09/2003 | CA2263566C Substituted 6,5-hetero-bicyclic derivatives |
| 09/09/2003 | CA2248953C Novel benzofuranone derivatives and process for producing the same |
| 09/09/2003 | CA2142121C Effects of actin filaments on fibrin clot structure and lysis |
| 09/04/2003 | WO2003073107A2 Neuropeptide receptor and uses thereof |
| 09/04/2003 | WO2003072780A1 Novel proteins, dnas thereof and use of the same |
| 09/04/2003 | WO2003072734A2 Bipolar trans carotenoid salts and their uses |
| 09/04/2003 | WO2003072558A2 Arylsulfone derivatives |
| 09/04/2003 | WO2003072539A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 09/04/2003 | WO2003072107A1 Substituted pyrimidinones and pyrimidinthiones |
| 09/04/2003 | WO2003072090A2 Use of tyrosine kinase inhibitors for treating cns disorders |
| 09/04/2003 | WO2003072067A2 Compositions and methods for treating epithelial and retinal tissue diseases |
| 09/04/2003 | WO2003072060A2 Polypeptide formulation |
| 09/04/2003 | WO2003072055A2 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors |
| 09/04/2003 | WO2003072027A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof |
| 09/04/2003 | WO2003062209A3 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin |
| 09/04/2003 | WO2003051805A3 Substituted phenyl naphthalenes as estrogenic agents |